[GAMUDA] YoY TTM Result on 30-Apr-2023 [#3]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
22-Jun-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2023
Quarter
30-Apr-2023 [#3]
Profit Trend
QoQ- 0.1%
YoY- 140.75%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
TTM Result
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
Revenue 12,042,352 6,690,148 4,102,750 3,557,062 4,235,817 4,280,504 4,025,404 20.01%
PBT 1,091,532 1,044,033 977,449 579,969 726,444 632,911 962,005 2.12%
Tax -177,461 961,497 -166,140 -172,143 -114,915 -157,507 -183,938 -0.59%
NP 914,071 2,005,530 811,309 407,826 611,529 475,404 778,067 2.71%
-
NP to SH 891,388 1,841,894 765,068 356,892 573,968 420,087 717,714 3.67%
-
Tax Rate 16.26% -92.09% 17.00% 29.68% 15.82% 24.89% 19.12% -
Total Cost 11,128,281 4,684,618 3,291,441 3,149,236 3,624,288 3,805,100 3,247,337 22.76%
-
Net Worth 11,570,586 10,689,469 9,704,568 8,847,620 8,595,168 8,021,825 7,747,954 6.90%
Dividend
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
Div 438,003 1,294,167 303,239 - 148,384 296,191 294,825 6.81%
Div Payout % 49.14% 70.26% 39.64% - 25.85% 70.51% 41.08% -
Equity
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
Net Worth 11,570,586 10,689,469 9,704,568 8,847,620 8,595,168 8,021,825 7,747,954 6.90%
NOSH 2,769,642 2,659,570 2,553,930 2,513,528 2,513,527 2,468,497 2,462,129 1.97%
Ratio Analysis
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
NP Margin 7.59% 29.98% 19.77% 11.47% 14.44% 11.11% 19.33% -
ROE 7.70% 17.23% 7.88% 4.03% 6.68% 5.24% 9.26% -
Per Share
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
RPS 435.04 251.60 161.50 141.52 168.54 173.42 163.66 17.67%
EPS 32.20 69.27 30.12 14.20 22.84 17.02 29.18 1.65%
DPS 15.82 48.67 12.00 0.00 6.00 12.00 12.00 4.70%
NAPS 4.18 4.02 3.82 3.52 3.42 3.25 3.15 4.82%
Adjusted Per Share Value based on latest NOSH - 2,659,570
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
RPS 426.78 237.10 145.40 126.06 150.12 151.70 142.66 20.01%
EPS 31.59 65.28 27.11 12.65 20.34 14.89 25.44 3.67%
DPS 15.52 45.87 10.75 0.00 5.26 10.50 10.45 6.80%
NAPS 4.1006 3.7883 3.4393 3.1356 3.0461 2.8429 2.7459 6.90%
Price Multiplier on Financial Quarter End Date
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
Date 30/04/24 28/04/23 29/04/22 30/04/21 30/04/20 30/04/19 30/04/18 -
Price 5.31 4.15 3.72 3.53 3.22 3.50 5.14 -
P/RPS 1.22 1.65 2.30 2.49 1.91 2.02 3.14 -14.56%
P/EPS 16.49 5.99 12.35 24.86 14.10 20.56 17.62 -1.09%
EY 6.06 16.69 8.10 4.02 7.09 4.86 5.68 1.08%
DY 2.98 11.73 3.23 0.00 1.86 3.43 2.33 4.18%
P/NAPS 1.27 1.03 0.97 1.00 0.94 1.08 1.63 -4.07%
Price Multiplier on Announcement Date
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
Date 25/06/24 22/06/23 29/06/22 24/06/21 24/06/20 27/06/19 27/06/18 -
Price 6.50 4.25 3.42 3.12 3.53 3.72 3.22 -
P/RPS 1.49 1.69 2.12 2.20 2.09 2.15 1.97 -4.54%
P/EPS 20.18 6.14 11.36 21.97 15.46 21.86 11.04 10.56%
EY 4.95 16.30 8.81 4.55 6.47 4.58 9.06 -9.57%
DY 2.43 11.45 3.51 0.00 1.70 3.23 3.73 -6.88%
P/NAPS 1.56 1.06 0.90 0.89 1.03 1.14 1.02 7.33%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment